Parkinson's Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder. It affects 3% to 4% of the population over the age of 65 years.

SERVICES

Biomarkers

Prodromal PD Biomarkers

  1. Non-motor symptoms
  2. Hyposmia (olfactory deficits)
  3. Visual abnormalities (oculomotor disturbances)
  4. Neuropsychiatric symptoms:
  • Depression
  • Anxiety
  • Anhedonia
  • Orthostatic Hypotension
  • Sleep disorders¬†
  • Constipation
  • Urogenital Dysfunction
  • Mood disorders
  • Neurobehavioral abnormalities

 

Clinical Biomarkers

  • Motor Symptoms
  • Akinesia
  • Bradykinesia
  • Hypokinesia
  • Postural Instability
  • Rigidity
  • Stopped Posture
  • Tremor at rest
  • Gait Impairment
  • Stiffness of arms, legs and trunk
  • Poor balance and coordination

 

Preclinical Biomarkers

  • Molecular imaging
  • DAT SPECT
  • Florodopa PET scan
  • Transcranial sonography
  • Magnetic Resonance Imaging
  • Optical Resonance Tomography
  • Biochemical Biomarkers
  • Genetic Biomarkers

Our approach

is a carefully validated, clinically realistic model for early diabetes mellitus screening and managing of the disease.

 

Our mathematical & computational tools

enable researchers and decision makers to make better informed decisions.